Table 3. Estimated economic costs associated with chronic hepatitis B infections per patient in different stages of the disease in 2012 .
| Chronic hepatitis B infection | Cirrhosis | Hepatocellular carcinoma | Average($) | |
| Direct medical costs($) |
1324.19
(42.79%) |
10843.1
(62.02%) |
24435.8
(74.14%) |
12201 |
| Direct non-medical costs($) |
334.19
(10.78%) |
1480.8
(8.48%) |
2877.6
(8.73%) |
1564.2 |
| Indirect costs($) |
1436.21
(46.43%) |
5159
(29.5%) |
5644.37
(17.13%) |
4079.8 |
| Total economic costs($) |
3094.59
100%) |
17483
(100%) |
32957.8
(100%) |
17845.13 |